全面了解与temozolomide相关的不良影响:基于FAERS数据库的不成比例分析
Yusen Zhou1, Peng Jia2, Yuting Fang1
1Department of Neurosurgery, The Affiliated Changsha Central Hospital, University of South China, Changsha, Hunan, China.
Frontiers in pharmacology
|September 9, 2024
概括
标准质瘤治疗药物Temozolomide有许多严重的不良事件 (AEs),这些不完全理解. 这项研究确定了已知的和新出现的副作用,突出了在temozolomide治疗期间需要更密切地监测患者的需要.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
背景情况:
- 泰莫佐洛米德是用于质瘤治疗的标准基化剂.
- 它的不良事件 (AEs) 尚未完全理解,并且经常被低估.
- 缺乏与temozolomide相关的副作用的系统文档.
研究的目的:
- 系统地分析和识别与temozolomide相关的不良事件.
- 评估在一个大型的真实世界数据库中对特定不良事件的不成比例报告.
- 发现潜在的新型或未被报告的temozolomide安全信号.
主要方法:
- 利用了来自美国FDA不良事件报告系统 (FAERS) 数据库的数据 (2004年第一季度 - 2023年第四季度).
- 采用了四个不成比例的分析算法来识别temozolomide和AE之间的统计学上显著的关联.
- 分析了20.079.906份病例报告,重点关注了15.152个与temozolomide相关的事件.
主要成果:
- 确定了352个首选术语 (PT) 和24个与temozolomide显著相关的系统器官类别 (SOC).
- 主要受影响的系统包括血液/淋巴系统 (n=4,325),检查 (n=3,925) 和皮肤/皮下组织 (n=1,347).
- 检测到预期的AEs (例如,贫血,恶心) 和很少报告的事件 (例如,无形性贫血,脑).
结论:
- 该研究证实了已知的temozolomide副作用,并揭示了许多严重的,未报告的事件.
- 这些发现强调需要加强对接受temozolomide治疗的患者的临床监测.
- 需要进一步的研究,以充分阐明安全性概况和优化temozolomide治疗.
相关概念视频
01:19Pharmacovigilance
788
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
237
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
237
01:25Increased Body Temperature
647
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
647
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
01:20Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149